You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9
BMC Cancer, August 2017
Stine Braendegaard Winther, Pia Österlund, Åke Berglund, Bengt Glimelius, Camilla Qvortrup, Halfdan Sorbye, Per Pfeiffer
The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Master||10||16%|
|Student > Ph. D. Student||7||11%|
|Student > Bachelor||7||11%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||30||47%|
|Biochemistry, Genetics and Molecular Biology||5||8%|
|Nursing and Health Professions||3||5%|
|Pharmacology, Toxicology and Pharmaceutical Science||3||5%|
|Economics, Econometrics and Finance||2||3%|